...
首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03).
【24h】

Evaluating the utility of a patient decision aid for potential participants of a prostate cancer trial (RAVES-TROG 08.03).

机译:为前列腺癌试验的潜在参与者评估患者决策辅助工具的效用(RAVES-TROG 08.03)。

获取原文
获取原文并翻译 | 示例
           

摘要

Randomised controlled trials (RCTs) can be hampered by poor patient accrual and retention. Decision aids (DAs) containing simple, evidence-based information, may assist patients with decision-making regarding trial participation. The current DA was of use for 95% of participants. Further evaluation of the DA in a RCT is currently underway.
机译:不良的患者累积和保留可能会阻碍随机对照试验(RCT)。包含简单的,基于证据的信息的决策辅助工具(DAs)可以帮助患者做出有关参与试验的决策。当前的DA已用于95%的参与者。目前正在进行RCT中DA的进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号